CoQ10 and exercise: higher blood levels are not the same as better performance
A guide to CoQ10 trials, endurance and fatigue outcomes, muscle-damage markers, formulations, safety and label claims.

CoQ10 reliably increases circulating levels, but recent pooled evidence finds exercise benefits small, unstable and low certainty.
A 2025 review identifies a biochemical-performance gap
A systematic review and meta-analysis published December 29, 2025 included 24 randomized studies. CoQ10 supplementation reliably increased blood concentrations, showing that participants were exposed to the ingredient. Exercise-performance effects were small and inconsistent. A possible chronic benefit became unstable after outliers were removed, while acute supplementation remained trivial. This is a clear example of why a blood-level change should not be marketed as proof of a functional result.

Endurance signals were not robust
The same analysis found that aerobic-endurance results looked favorable in primary analyses but became borderline after outlier exclusion. Strength and anaerobic outcomes changed little. Evidence certainty was rated very low to low because of heterogeneity and moderate-to-high risk of bias. A headline that says CoQ10 supports energy production leaves out the central clinical question: did the athlete perform meaningfully better, and would the result repeat in a new trial?
Muscle-damage markers tell another story
A 2024 meta-analysis of 28 randomized trials reported reductions in creatine kinase, lactate dehydrogenase, myoglobin and an oxidative-stress marker. These laboratory outcomes can support research on recovery but do not automatically establish less soreness, restored force or better next-day training. Biomarker values also vary with exercise model and timing. A product should not convert a lower marker into a promise of faster recovery unless the functional outcomes support that conclusion.
Formulation affects exposure
CoQ10 products use ubiquinone, ubiquinol, softgels, powders and delivery systems intended to change absorption. A trial of one formulation cannot validate another simply because both list CoQ10. Compare form, amount, food instructions, duration and measured exposure. Higher blood levels may show better absorption while still failing to improve performance. Bioavailability and efficacy are related questions, not synonyms.
Fatigue is subjective and context-dependent
The 2025 review found suggestive evidence for lower subjective fatigue, but results changed with sensitivity analyses. Fatigue ratings can matter, yet they are influenced by sleep, mood, expectations, training load and the exercise protocol. Blinding is especially important when a supplement is marketed as an energy product. A subjective benefit should be reported as such, without implying that power output, endurance or recovery also improved.

Review safety and medication use
CoQ10 is generally tolerated in many studies but can cause digestive effects and may interact with warfarin or medicines affecting blood pressure and glucose. People with medical conditions, pregnancy or scheduled procedures need individualized guidance. Athletes should consider independent product certification. Long-term use also creates a cost question: an unstable small effect may not justify months of supplementation when the practical outcome is undefined.
Define what success would look like
An athlete considering CoQ10 should name a specific test, keep training and diet stable enough to interpret, and avoid changing several products simultaneously. Blood concentration alone is not the goal. Current reviews support the conclusion that CoQ10 changes exposure and may influence selected markers or fatigue, while dependable performance improvement remains unproven. Product claims should reflect that uncertainty rather than turning mitochondrial biology into a guarantee of more athletic energy.
Do not let antioxidant language settle the adaptation question
Exercise produces oxidative signals that can contribute to training adaptation as well as temporary cellular stress. Lowering an oxidative-stress marker is therefore not automatically synonymous with better long-term adaptation. CoQ10 trials need to connect biomarkers with strength, endurance, power or repeated training outcomes, and they should examine whether chronic use changes the response to exercise over time. The 2024 review found several favorable laboratory markers, while the 2025 performance analysis judged functional effects modest and unstable. Reading them together prevents a one-sided conclusion. Athletes should be wary of claims that every rise in oxidative stress is damage that must be suppressed. The goal is better health and performance, not the lowest possible value for one marker after a controlled workout. Functional outcomes and training progression remain the more meaningful standard.
Independent trials using standardized formulations and prespecified sport outcomes would clarify whether any subgroup receives a repeatable benefit beyond higher circulating CoQ10.
Sources & further reading
This article provides educational information. Ask a qualified clinician or pharmacist about your symptoms, medical conditions, medicines and supplement interactions.